SAN DIEGO, Dec. 4, 2014 (GLOBE NEWSWIRE) -- Icon Vapor, Inc. (OTC Symbol 'ICNV') announced today that the newly acquired Green Tree Syndicate operation just booked approximately $1M in new orders for their Canadian based businesses.
ICON Vapor President Dan Balsiger announced that, "Our Green Tree Syndicate business unit is making great strides in the Canadian marketplace with these latest orders for just shy of $1M in new products, to be delivered in the 1st quarter of 2015. We anticipate that Green Tree will continue to expand our market share in Canada in 2015, generating strong quarter on quarter sales growth for ICON."
Mr. Balsiger further commented that, "As our general sales continue to increase at their current pace, we should be able to generate sustainable profitability as we move into 2015. ICON believes that this progress will provide a healthy boost to our stock performance in the near future."
About ICON Vapor, Inc. (www.IconVapor.com)
Headquartered in San Diego, California, Icon Vapor engages in the manufacture and distribution of electronic cigarettes. The company offers disposable and starter kits e-cigarettes as well as cartomizers in tobacco and menthol flavors branded under the ICON Vapor Products line. For further information please contact the Company at:
(858.509.2783 or IR@IconVapor.com)
Safe Harbor Statement
This press release may contain forward looking statements and or observations which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties include but are not limited to information as contained within the Company's most current quarterly reports, annual reports, and or other such filings as may be accessed through the OTC Markets website. Furthermore, the Company disclaims any intention or obligation to update or revise any such forward looking statements, whether as a result of new information, future events, or otherwise. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new product lines noting there is no assurance that we will generate enough revenues to offset those costs. Additional product offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the variables as associated with the general business channel we are operating in, the impact of which cannot be predicted at this time including risks as associated with our product and recent FDA pronouncements. Additionally, our 1-A registration statement may generate additional free trading shares to the marketplace at a pre-determined price which may impact our share pricing within the OTC marketplace in a manner that we cannot predict.